Effectiveness of collaborative care for depressed Chinese people in primary care

ISRCTN ISRCTN87321950
DOI https://doi.org/10.1186/ISRCTN87321950
Secondary identifying numbers NHRI-EX97-9706PI
Submission date
05/04/2008
Registration date
01/05/2008
Last edited
04/02/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Shen-Ing Liu
Scientific

Department of Psychiatry
Mackay Memorial Hospital
No 45
Ming-Shan Road
Tam-Shui
Chu-Wui
Taipei County
25115
Taiwan

Study information

Study designRandomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleEffectiveness of culturally sensitive collaborative treatment of depressed Chinese people in primary care: a randomised controlled trial
Study objectives1. Depressed patients who receive intervention have improved treatment outcomes compared to patients who receive usual care
2. Depressed patients who perceive biomedical causes of depression have improved treatment outcomes compared to patients who perceive non-medical causes of depression
3. Depressed patients with history of seeking medical treatment have improved treatment outcomes compared to patients with history of seeking non-medical treatment
4. Depressed patients with low stigmatisation have improved treatment outcomes compared to patients with high stigmatisation
Ethics approval(s)Mackay Memorial Hospital Institutional Review Board. Date of approval: 24/04/2007 (ref: MMH-I-S-241 [2])
Health condition(s) or problem(s) studiedDepressive disorder
InterventionThe intervention includes consultation to depressed patients by a psychiatrist, treatment of depression by general medical doctors based on established guidelines, and Care Management by a Care Manager under the supervision of a psychiatrist.

The control group of participants will receive the "standard care."

Duration of interventions: 24 weeks
Intervention typeOther
Primary outcome measureRate of adherence to treatment initiation, assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point.
Secondary outcome measuresThe following will be assessed by blind assessors at baseline and every four weeks from week 2 until week 26 or end point:
1. Rate of adherence to medication treatment
2. Rate of treatment completers
3. Rate of responders
4. Overall life satisfaction
Overall study start date01/05/2008
Completion date31/07/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants400
Key inclusion criteria1. Patients who attend non-psychiatric clinics
2. Patients with Major Depressive Disorder (MDD), defined as a positive screen using the Patient Health Questionnaire (PHQ-9), confirmed with the Schedules of Clinical Assessment in Neuropsychiatry (SCAN) interview
3. Men or women aged 18 or older
4. Able to participate in a clinical diagnostic interview in either Mandarin or Fukienese dialects
5. Individuals who are willing to be followed up concerning their depression symptoms
6. Individuals who have completed a written consent form
Key exclusion criteria1. Women who are pregnant, breast-feeding or planning pregnancy within the next year
2. Patients with serious suicidal risk
3. Patients with unstable medical illnesses
4. Clinical or laboratory evidence of hypothyroidism
5. Patients with comorbid severe mental disorders including:
5.1. Organic mental disorders
5.2. Alcohol or substance abuse disorders active within the last year
5.3. Schizophrenia
5.4. Delusional disorder
5.5. Psychotic disorders not elsewhere classified
5.6. Bipolar disorder
5.7. Mood congruent or mood incongruent psychotic features
6. Patients with history of treatment by a psychiatrist in the past 4 months
Date of first enrolment01/05/2008
Date of final enrolment31/07/2012

Locations

Countries of recruitment

  • Taiwan

Study participating centre

Department of Psychiatry
Taipei County
25115
Taiwan

Sponsor information

National Health Research Institutes (Taiwan)
Government

35 Keyan Road
Zhunan
Miaoli County
350
Taiwan

Website http://english.nhri.org.tw
ROR logo "ROR" https://ror.org/02r6fpx29

Funders

Funder type

Government

National Health Research Institutes (Taiwan)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2018 Yes No

Editorial Notes

04/02/2019: Publication reference added.